Viewing Study NCT06105892


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2025-12-26 @ 1:23 PM
Study NCT ID: NCT06105892
Status: RECRUITING
Last Update Posted: 2024-11-18
First Post: 2023-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Sponsor: New Jersey Institute of Technology
Organization:

Study Overview

Official Title: Eye Recovery Automation for Post Injury Dysfunction
Status: RECRUITING
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: iRAPID
Brief Summary: This study will test a portable virtual reality (VR) system with integrated eye tracking called Virtual Eye Rotation Vision Exercises (VERVE). The proposed VERVE platform will deliver vergence therapy in an automated manner. This research will involve 30 non-traumatic brain injury (TBI) binocularly normal (BNC) Veterans and 50 post-traumatic convergence insufficiency (PTCI) Veterans who will undergo Active and Sham therapy (equally divided groups) to determine the effectiveness of VERVE vergence therapy.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
W81XWH22C0146 OTHER_GRANT U.S. Army Medical Research and Development Command View